|
News Releases
Events
|
|
Newsroom | 2008 News
Releases
December
08, 2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER 19TH ANNUAL HEALTHCARE CONFERENCE
December 08,
2008
CYPRESS BIOSCIENCE TO PRESENT AT RBC CAPITAL MARKETS HEALTHCARE CONFERENCE
November 10, 2008
CYPRESS BIOSCIENCE ANNOUNCES THIRD QUARTER 2008 RESULTS
October 31,
2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER 19TH ANNUAL HEALTHCARE CONFERENCE
October 24, 2008
CYPRESS BIOSCIENCE LAUNCHES TWO NEW PERSONALIZED MEDICINE SERVICES FOR
RHEUMATOLOGISTS
October 20, 2008
FDA DEFERS FINAL ACTION ON MILNACIPRAN NEW DRUG APPLICATION
October 2, 2008
CYPRESS BIOSCIENCE TO PRESENT AT UPCOMING INVESTOR AND INDUSTRY CONFERENCES
September 18, 2008
CYPRESS BIOSCIENCE TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
September 4, 2008
CYPRESS BIOSCIENCE TO PARTICIPATE IN CITI'S 3RD ANNUAL BIOTECH DAY
August 8,
2008
CYPRESS BIOSCIENCE ANNOUNCES SECOND QUARTER 2008 RESULTS
July 29, 2008
CYPRESS BIOSCIENCE TO PRESENT AT OPPENHEIMER SMALL & MID CAP CLINICAL & REGULATORY
CONFERENCE
June 23, 2008
CYPRESS BIOSCIENCE TO PRESENT AT JEFFERIES 2ND ANNUAL HEALTHCARE CONFERENCE
June 9, 2008
CYPRESS BIOSCIENCE TO PRESENT AT NEEDHAM & COMPANY BIOTECHNOLOGY
AND MEDICAL TECHNOLOGY CONFERENCE
May 23, 2008
CYPRESS BIOSCIENCE TO PRESENT AT FBR CAPITAL MARKETS SPRING INVESTOR
CONFERENCE
May 19, 2008
CYPRESS BIOSCIENCE TO PRESENT AT CITI'S HEALTH CARE CONFERENCE
May 12, 2008
CYPRESS BIOSCIENCE ANNOUNCES FIRST QUARTER 2008 RESULTS
May 6, 2008
CYPRESS BIOSCIENCE TO PRESENT AT THE NEUROTECH INDUSTRY INVESTING & PARTNERING
CONFERENCE
May 1, 2008
CYPRESS BIOSCIENCE TO PRESENT AT DEUTSCHE BANK HEALTH CARE CONFERENCE
March 17, 2008
CYPRESS BIOSCIENCE ANNOUNCES FOURTH QUARTER AND FISCAL YEAR END 2007
RESULTS
March 14, 2008
CYPRESS BIOSCIENCE TO PRESENT AT COWEN & COMPANY 28TH ANNUAL HEALTH
CARE CONFERENCE
March 4, 2008
CYPRESS BIOSCIENCE CLOSES ACQUISITION OF PROPRIUS PHARMACEUTICALS
February 25, 2008
CYPRESS BIOSCIENCE TO ACQUIRE PROPRIUS PHARMACEUTICALS
February 21, 2008
FOREST AND CYPRESS ANNOUNCE FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR
MILNACIPRAN FOR THE TREATMENT OF FIBROMYALGIA
| |
 |